EC Neurology

Mini Review Volume 17 Issue 9 - 2025

Neurology and Epilepsy: Innovation, Burden and Future

Ahed J Alkhatib1,2,3* and A’aesha Mohammad Mahmoud Qasem4

1Retired, Department of Legal Medicine, Toxicology and Forensic Medicine, Jordan University of Science and Technology, Jordan

2Department of Medicine and Critical Care, Department of Philosophy, Academician Secretary of Department of Sociology, International Mariinskaya Academy, Jordan

3Cypress International Institute University, Texas, USA

4Aljawabreh Trading Est, Jordan

*Corresponding Author: Ahed J Alkhatib, Retired, Department of Legal Medicine, Toxicology and Forensic Medicine, Jordan University of Science and Technology and Department of Medicine and Critical Care, Department of Philosophy, Academician Secretary of Department of Sociology, International Mariinskaya Academy, Jordan and Cypress International Institute University, Texas, USA.
Received: August 26, 2025; Published: September 16, 2025



Epilepsy is one of the oldest and most widespread neurological disorders described in the medical literature. However, it is still one of the most difficult to manage. With diagnostic and therapeutic advances and neurobiological insights, epilepsy continues to pose great clinical and social challenges. Over 50 million people worldwide have epilepsy but over 75% of patients in low and middle-income countries do not receive treatment [1,2]. For a neurologist who sees patients, epilepsy is at the intersection of brain and behavior and genes and public health. In this way, it involves more than seizures.

 Keywords: Epilepsy; Seizures; Neurology; Artificial Intelligence

  1. Mugumbate R. “Epilepsy in resource limited settings: managing quality of life”. Taylor and Francis (2025).
  2. Thijs RD., et al. “Epilepsy in adults”. Lancet10172 (2019): 689-701.
  3. Löscher W., et al. “Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options”. Pharmacological Reviews3 (2020): 606-638.
  4. Ho WS., et al. “Laser interstitial thermal therapy (LITT) for pediatric brain tumors. A review”. Neuro-Oncology Pediatrics 14 (2025): wuaf004.
  5. Kanner AM. “Neuromodulation in epilepsy: Vagus nerve stimulation, responsive neurostimulation, and deep brain stimulation”. Current Neurology and Neuroscience Reports 7 (2020): 17.
  6. Kalousios S., et al. “Memory optimized random forest classifier for EEG seizure detection in implantable monitoring and closed-loop neurostimulation devices”. Journal of Neural Engineering3 (2025): 036023.
  7. Meyer AC., et al. “Global disparities in the epilepsy treatment gap: A systematic review”. Epilepsia 12 (2010): 2520-2531.
  8. Jacoby A., et al. “Epilepsy and social identity: The stigma of a chronic neurological disorder”. Lancet Neurology3 (2005): 171-178.
  9. Devinsky O., et al. “Sudden unexpected death in epilepsy: Epidemiology, mechanisms, and prevention”. Lancet Neurology10 (2016): 1075-1088.
  10. Kanner AM. “Depression and epilepsy: A new perspective on two closely related disorders”. Epilepsy Currents 5 (2006): 141-146.
  11. World Health Organization. “Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031”. Geneva: WHO (2022).

Ahed J Alkhatib and A’aesha Mohammad Mahmoud Qasem. “Neurology and Epilepsy: Innovation, Burden and Future”. EC Neurology  17.9 (2025): 01-03.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net